International network for natural sciences – research journal
  • mendeley icon
  • linkedin icon
  • google plus icon
  • twitter icon
  • google scholar icon
  • facebook icon

Analysis of certain clinical characteristics of hepatitis delta virus (HDV) patients

By: Ikram-Ul Haq, Iqra Baloch, Sikander Ali Sangrasi1, Noman Ali, Maria Rana, Sheeraz Ali

Key Words: Hepatitis D, Clinical diagnosis, Antioxidants, HCT, RBC, Flavonoids

Int. J. Biosci. 15(4), 387-394, October 2019.

DOI: http://dx.doi.org/10.12692/ijb/15.4.387-394

Certification: ijb 2019 0351 [Generate Certificate]

Abstract

Acute hepatitis D (delta) is a chronic liver disease caused with co-infection of hepatitis D virus (HDV) and hepatitis B virus (HBV). In this study, blood serum samples are screened for HBV and HDV infections. The 4 confirmed out of 14 patients with real-time PCR for HDV infected were subjected for further comparative clinical analysis. Among the patients, the hemoglobin (17.18±0.149g/dL) and HCT (50.90±0.235%) levels increased significantly than standard reference values. Similarly, proline and flavonoids also observed higher, while alanine aminotransferase (ALT) and antioxidants decreased (p<0.05) in the patients than normal reference values for the healthy person. These facts could be developed due to HDV stress on the body. The HDV patients showed inversely proportional relations in the levels of hemoglobin and platelets. These differential parameters could be improved with the good nutrients or supplements, which may be helpful for the survival of these patients. This present study could be helpful proper maintenance of HDV patients under HDV treatment.

| Views 76 |

| Views 76 |

Analysis of certain clinical characteristics of hepatitis delta virus (HDV) patients

Ahn J, Gish RG. 2014. Hepatitis D virus: A call to screening. Journal of Gastroenterology and Hepatology 10(10), 647-86.

Behrens JT. 1997. Principles and procedures of exploratory data analysis. Psychological Methods 2(2), 131-160.

Chakravarti A, Ukey A, Bajaj P, Saragade P. 2017. A study of hematological profile in patients of chronic renal failure undergoing hemodialysis at a tertiary health care institute. MVP Journal of Medical Sciences 4(2), 107-112.

Evenson MA, Carmack GD. 1979. Clinical Chemistry. Anals of Chemistry 51(5), 35-79.

Hackman BA, Plouffe JF, Benson RF. 1996. Fields BS, Breiman RF. Comparison of Binax Legionella Urinary Antigen EIA kit with Binax RIA Urinary Antigen kit for detection of Legionella pneumophila serogroup 1 antigen. Journal of Clinical Microbiology 34(6), 1579-1580.

Han L, Zhang HW, Xie JX, Zhang Q, Wang HY, Cao GW. 2011. A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus. Worlds Journal of Gastroenterology 17, 4321-4333.

Haq I-U, Kumar D, Hussain S, Mirza MR, Hameed A, Gill NP. 2018. Comparative study of β-thalassemia major among the patients from urban and rural population in Hyderabad region. International Journal of Biosciences 12(3), 224-234.

Harthoorn-Lasthuizen EJ, Lindemans J, Langenhuijsen MM. 1999. Influence of iron deficiency anaemia on haemoglobin A2 levels: possible consequences for beta-thalassaemia screening. Scandinavian Journal of Clinical and Laboratory Investigation 59(1), 65-70.

Henley S. 1983. Principles and procedure of statistics. A Biometrical Approach by Robert G.D. Steel and James H. Torric … Auckland : McGraw-Hill.

Ho E, Deltenre P, Nkuize M, Delwaide J, Colle I, Michielsen P. 2013. Coinfection of hepatitis B and hepatitis delta virus in Belgium: A multicenter BASL study. Prospective epidemiology and comparison with HBV mono-infection. Journal of Medical Virology 85(9), 1513-1517.

Huang CR, John S. 2014. Hepatitis D virus infection, replication and cross-talk with the hepatitis B virus. Worlds Journal of Gastroenterology  20(40), 14589-14597.

Hughes SA, Wedemeyer H, Harrison PM. 2011. Hepatitis delta virus. The Lancet 37, 73-85.

Korotkova EI, Freinbichler W, Linert W, Dorozhko EV, Bukkel MV, Plotnikov EV, Voronova OA. 2013. Study of total antioxidant activity of human serum blood in the pathology of alcoholism. Molecules 18(2), 1811-1818.

Kramvis A. 2004. Low Genetic Diversity despite Hyperendemicity of Hepatitis B Virus Genotype E throughout West Africa. Journal of Infectious Disease 190, 400-408.

Le Gal F, Brichler S, Drugan T, Alloui C, Roulot D, Pawlotsky JM, Deny P, Gordian E. 2017. Genetic diversity and worldwide distribution of the deltavirus genus: A study of 2,152 clinical strains. Hepatology 66(6), 1826-1841.

Le Gal F, Gault E, Ripault MP, Serpaggi J, Trinchet JC, Gordien E, Deny P. 2006. Eighth major clade for hepatitis delta virus. Emerging Infectious Disease 12, 1447-1450.

Le Gal F, Gordien E, Affolabi D, Hanslik T, Alloui C, Deny P, Gault E. 2005. Quantification of hepatitis delta virus RNA in serum by consensus real-time PCR indicates different patterns of virological response to interferon therapy in chronically infected patients. Journal of Clinical Microbiology 43(5), 2363-2369.

Lewis SM, Garvey B, Manning R, Sharp SA, Wardle J. 1991. Lauryl sulphate haemoglobin: a non‐hazardous substitute for HiCN in haemoglobinometry. Clinical and Laboratory Haematology 13(3), 279-290.

Lin CL, Kao JH. 2011. The clinical implications of hepatitis B virus genotype: Recent advances. Journal of Gastroenterology and Hepatology 26, 123-130.

 

Livingston SE, Simonetti JP, Bulkow LR, Homan CE, Snowball MM, Cagle HH, Negus SE, McMahon BJ. 2007. Clearance of Hepatitis B e Antigen in Patients With Chronic Hepatitis B and Genotypes A, B, C, D, and F. Gastroenterology 133, 1452-1457.

Malik A, Singhal DK, Albanyan A, Husain SA, Kar P. 2012. Hepatitis B virus gene mutations in liver diseases: A report from New Delhi. PLoS One 7(6), e39028.

Mederacke I, Bremer B, Heidrich B, Kirschner J, Deterding K, Bock T, Wursthorn K, Manns MP, Wedemeyer H. 2010. Establishment of a novel quantitative hepatitis D virus (HDV) RNA assay using the Cobas TaqMan platform to study HDV RNA kinetics. Journal of Clinical Microbiology 48, 2022-2029.

Mosca A, Paleari R, Ivaldi G, Galanello R, Giordano PC. 2009. The role of haemoglobin A 2 testing in the diagnosis of thalassaemias and related haemoglobinopathies. Journal of Clinical Pathology 62(1), 13-17.

Negro F. 2014. Hepatitis D virus coinfection and superinfection. Cold Spring Harbor Perspectives in Medicine 4(11), a021550.

Nguyen VTT, Law MG, Dore GJ. 2009. Hepatitis B-related hepatocellular carcinoma: Epidemiological characteristics and disease burden. Journal of Viral Hepatitis 16(7), 453-463.

Oo YH, Mutimer DJ. 2015. Hepatitis B and D. Medicine (United Kingdom) 43(10), 599-606.

Pascarella S, Negro F. 2011. Hepatitis D virus: An update. Liver International 31(1), 7-21.

Polish LB, Gallagher M, Fields HA, Hadler SC. 1993. Delta hepatitis: Molecular biology and clinical and epidemiological features. Clinical Microbiology Reviews 6(3), 211-229.

Quinn GP, Keough MJ. 2002. Experimental Design and Data Analysis for Biologists (1st Ed) Cambridge, Cambridge University Press.

Radjef N, Gordien E, Ivaniushina V, Gault E, Anais P, Drugan T, Trinchet JC, Roulot D, Tamby M, Milinkovitch MC, Deny P. 2004. Molecular Phylogenetic Analyses Indicate a Wide and Ancient Radiation of African Hepatitis Delta Virus, Suggesting a Deltavirus Genus of at Least Seven Major Clades. Journal of Virology 78, 2537-2544.

Rizzetto M, Shih JW, Gerin JL. 1980. The hepatitis B virus-associated delta antigen: isolation from liver, development of solid-phase radioimmunoassays for delta antigen and anti-delta and partial characterization of delta antigen. Journal of Immunology 125(1), 318-324.

Rizzetto M. 1983. The Delta Agent. Hepatology 3(5), 729-737.

Rizzetto M. 2015. Hepatitis D virus: Introduction and epidemiology. Cold Spring Harbor Perspectives in Medicine 5(7), a021576.

Seo DH, Whang DH, Song EY, Han KS. 2015. Occult hepatitis B virus infection and blood transfusion. World Journal of Hepatology 7(3), 600-606.

Shah VB, Shah BS, Puranik GV. 2011. Evaluation of non cyanide methods for hemoglobin estimation. Indian Journal of Pathology and Microbiology 54(4), 764-768.

Spearman CW, Afihene M, Ally R, Apica B, Awuku Y, Cunha L, Dusheiko G, Gogela N, Kassianides C, Kew M, Lam P, Lesi O, Lohouès-Kouacou MJ, Mbaye PS, Musabeyezu E, Musau B, Ojo O, Rwegasha J, Scholz B, Shewaye AB, Tzeuton C, Sonderup MW. 2017. Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets. Lancet Gastroenterology and Hepatology 2, 900-909.

Stefova M, Stafilov T, Kulevanova S. 2003. Analysis of Flavonoids (J. Cazes, Ed), Marcel Dekker, Inc.

Sun Y, Oberley LW, Li Y. 1988. A simple method for clinical assay of superoxide dismutase. Clinical Chemistry 34(3), 497-500.

Valadez-Bustos MG, Aguado-Santacruz GA, Tiessen-Favier A, Robledo-Paz A, Munoz-Orozco A, Rascon-Cruz Q, Santacruz-Varela A. 2016, A reliable method for spectrophotometric determination of glycine betaine in cell suspension and other systems. Anals of Biochemistry 498, 47-52.

Vos FE, Schollum JB, Coulter CV, Doyle TC, Duffull SB, Walker RJ. 2011. Red blood cell survival in long-term dialysis patients. American Journal of Kidney Diseases 44(4), 715-719.

Wang HB, Wang QY, Yuan Q, Shan XY, Fu GH. 2017. Alanine aminotransferase is more sensitive to the decrease in hepatitis B virus-DNA load than other liver markers in chronic hepatitis B patients. Journal of Clinical Laboratory Analysis 31(6), 1-4.

Wen YM, Wang YX. 2009. Biological features of hepatitis B virus isolates from patients based on full-length genomic analysis. Reviews in Medical Virology 19(1), 57-64.

WHO. 2017. Hepatitis B fact sheet no. 204. Geneva 1211, Switzerland.

Xiridou M, Borkent-Raven B, Hulshof J, Wallinga J. 2009. How hepatitis D virus can hinder the control of hepatitis B virus. PLoS One 4(4), e5247.

Yang HI, Yeh SH, Chen PJ, Iloeje UH, Jen CL, Su J, Wang LY, Lu SN, You SL, Chen DS, Liaw YF, Chen CJ. 2008. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. Journal of the National Cancer Institute 101, 1066-1082.

Yeung LTF, Roberts EA. 2010. Hepatitis B in childhood: An update for the paediatrician. Journal of Paediatrics and Child Health 30(1), 5-18.

Yu MW, Yeh SH, Chen PJ, Liaw YF, Lin CL, Liu CJ, Shih WL, Kao JH, Chen DS, Chen CJ. 2005. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: A prospective study in men. Journal of the National Cancer Institute 97(4), 265-272.

Yurdaydın C, Idilman R, Bozkaya H, Bozdayi AM. 2010. Natural history and treatment of chronic delta hepatitis. Journal of Viral Hepatitis 17(11), 749-756.

Ikram-Ul Haq, Iqra Baloch, Sikander Ali Sangrasi1, Noman Ali, Maria Rana, Sheeraz Ali.
Analysis of certain clinical characteristics of hepatitis delta virus (HDV) patients.
Int. J. Biosci. 15(4), 387-394, October 2019.
https://innspub.net/ijb/analysis-certain-clinical-characteristics-hepatitis-delta-virus-hdv-patients/
Copyright © 2019
By Authors and International Network for
Natural Sciences (INNSPUB)
https://innspub.net
brand
innspub logo
english language editing
  • CALL FOR PAPERS
    CALL FOR PAPERS
    Publish Your Article
  • CALL FOR PAPERS
    CALL FOR PAPERS
    Submit Your Article
INNSPUB on FB
Email Update